- Home
- AUPH vs OPEN Comparison
AUPH vs OPEN Comparison
Compare AUPH & OPEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- OPEN
- Stock Information
- Founded
- AUPH 1993
- OPEN 2014
- Country
- AUPH Canada
- OPEN United States
- Employees
- AUPH N/A
- OPEN N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- OPEN Real Estate
- Sector
- AUPH Health Care
- OPEN Finance
- Exchange
- AUPH Nasdaq
- OPEN Nasdaq
- Market Cap
- AUPH 999.8M
- OPEN N/A
- IPO Year
- AUPH 1999
- OPEN N/A
- Fundamental
- Price
- AUPH $8.18
- OPEN $0.76
- Analyst Decision
- AUPH Strong Buy
- OPEN Hold
- Analyst Count
- AUPH 2
- OPEN 5
- Target Price
- AUPH $11.50
- OPEN $1.70
- AVG Volume (30 Days)
- AUPH 1.3M
- OPEN 56.0M
- Earning Date
- AUPH 05-05-2025
- OPEN 05-06-2025
- Dividend Yield
- AUPH N/A
- OPEN N/A
- EPS Growth
- AUPH N/A
- OPEN N/A
- EPS
- AUPH 0.04
- OPEN N/A
- Revenue
- AUPH $235,133,000.00
- OPEN $5,153,000,000.00
- Revenue This Year
- AUPH $11.86
- OPEN $3.84
- Revenue Next Year
- AUPH $24.96
- OPEN $21.51
- P/E Ratio
- AUPH $204.50
- OPEN N/A
- Revenue Growth
- AUPH 33.97
- OPEN N/A
- 52 Week Low
- AUPH $4.86
- OPEN $0.72
- 52 Week High
- AUPH $10.67
- OPEN $3.09
- Technical
- Relative Strength Index (RSI)
- AUPH 56.33
- OPEN 31.59
- Support Level
- AUPH $7.92
- OPEN $0.90
- Resistance Level
- AUPH $8.32
- OPEN $1.07
- Average True Range (ATR)
- AUPH 0.34
- OPEN 0.11
- MACD
- AUPH 0.07
- OPEN -0.01
- Stochastic Oscillator
- AUPH 90.64
- OPEN 12.22
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.